Ben Jun Qin
Fortuna: 214 M $ al 30/09/2026
Fortuna: 214 M $ al 30/09/2026
Ben Jun Qin currently works at Guilin Layn Pharmaceutical Co. Ltd., as Chairman.
Mr. Qin also formerly worked at Guilin Layn Natural Ingredients Corp., as Chairman & General Manager from 2014 to 2024 and Guilin Layn Biotechnology Co. Ltd., as Executive Director.
Mr. Qin received his Masters Business Admin degree from Tsinghua University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 22/12/2025 | 211.389.592 ( 28,7 % ) | 214 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Guilin Layn Pharmaceutical Co. Ltd.
Guilin Layn Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and disitributes pharmaceutical products | Presidente | 06/10/2010 |
| Empresas | Cargo | Fin |
|---|---|---|
| GUILIN LAYN NATURAL INGREDIENTS CORP. | Director Ejecutivo | 04/12/2024 |
Guilin Layn Biotechnology Co. Ltd. | Director/Miembro de la Junta | 06/03/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guilin Layn Natural Ingredients Corp.
Guilin Layn Natural Ingredients Corp. Food: Specialty/CandyConsumer Non-Durables Engages in research, development and production of natural botanical ingredients and sweetener extracts | Consumer Non-Durables |
Guilin Layn Pharmaceutical Co. Ltd.
Guilin Layn Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and disitributes pharmaceutical products | Health Technology |
Guilin Layn Biotechnology Co. Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.